GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Benevolent AI (XAMS:BAI) » Definitions » Cash Payments

Benevolent AI (XAMS:BAI) Cash Payments


View and export this data going back to 2022. Start your Free Trial

What is Benevolent AI Cash Payments?

Cash Payments only applicable to companies reporting Cash Flow from Operations in direct method.


Benevolent AI Business Description

Traded in Other Exchanges
N/A
Address
4-8 Maple Street, London, GBR, W1T 5HD
Benevolent AI is a clinical-stage AI-enabled drug discovery company. It delivers novel drug candidates with a higher probability of clinical success than those developed using traditional methods. The Benevolent Platform powers a growing in-house pipeline of over 20 drug programmes, spanning from target discovery to clinical studies, and it maintains commercial collaborations with pharmaceutical companies.